High heterogeneity and low reliability in the diagnosis of major depression will impair the development of new drugs
Major depressive disorder is a common diagnosis associated with a high burden of disease that has proven to be highly heterogeneous and unreliable. Treatments currently available demonstrate limited efficacy and effectiveness. New drug development is urgently required but is likely to be hindered by...
Main Authors: | Samuel M. Lieblich, David J. Castle, Christos Pantelis, Malcolm Hopwood, Allan Hunter Young, Ian P. Everall |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2015-10-01
|
Series: | BJPsych Open |
Online Access: | https://www.cambridge.org/core/product/identifier/S205647240000106X/type/journal_article |
Similar Items
-
Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications
by: Malcolm Hopwood
Published: (2023-04-01) -
Cognitive impairment and fMRI in major depression.
by: Ebmeier, K, et al.
Published: (2006) -
Pattern of impaired working memory during major depression.
by: Rose, E, et al.
Published: (2006) -
Major Depressive Disorder is Associated with Impaired Mitochondrial Function in Skin Fibroblasts
by: Kerstin Kuffner, et al.
Published: (2020-04-01) -
Functional Impairment and Quality of Life of patients with Major Depressive Disorder in Euthymia
by: Gayathri Madhu, et al.
Published: (2023-07-01)